|
esophageal cancer (EC):食管癌(EC)
gastric cancer (GC):胃癌(GC)
Esophageal Squamous Cell Carcinoma:食管鳞状细胞癌/食管鳞癌(ESCC)
Gastric/Gastroesophageal Junction Adenocarcinoma:胃/胃食管交界处(G/GEJ)腺癌
programmed cell death-1 (PD-1):细胞程序性死亡受体1
programmed cell death-1 ligand (PD-L1):细胞程序性死亡配体-1
Tislelizumab:替雷利珠单抗
pembrolizumab:帕博利珠单抗(Keytruda,K药)
nivolumab:纳武利尤单抗
cisplatin:顺铂
fluorouracil:氟尿嘧啶
oxaliplatin:奥沙利铂
capecitabine:卡倍他滨
duration of response (DoR):缓解持续时间
disease control rate (DCR):疾病控制率
primary endpoint:主要终点
secondary endpoints:次要终点
Exploratory endpoints:探索性终点
|
|